Related Experiment Video

Updated: May 7, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

4.9K

Relationship between serum neopterin levels and coronary heart disease

Z Y Liu1, Y D Li

  • 1Department of Cardiology, Nanyang Central Hospital, Nanyang, China.

Genetics and Molecular Research : GMR
|October 12, 2013
PubMed

Insights

Serum neopterin levels are elevated in acute myocardial infarction and unstable angina, indicating its role in coronary heart disease (CHD) development. Higher neopterin is linked to vulnerable plaques, suggesting it as a biomarker for CHD risk.

Area of Science:

  • Cardiology
  • Immunology
  • Biochemistry

Background:

  • Coronary heart disease (CHD) is a leading cause of mortality worldwide.
  • Inflammation plays a critical role in the pathogenesis of CHD.
  • Neopterin, a marker of immune system activation, has been implicated in various inflammatory conditions.

Purpose of the Study:

  • To investigate the association between serum neopterin levels and different clinical presentations of CHD.
  • To explore the relationship between neopterin and coronary artery stenosis severity and plaque characteristics.
  • To evaluate neopterin as a potential biomarker for vulnerable plaques in CHD patients.

Main Methods:

  • Serum neopterin levels were measured using enzyme-linked immunosorbent assay (ELISA).
  • Eighty-six CHD patients were categorized into acute myocardial infarction (AMI), unstable angina pectoris (UAP), and stable angina pectoris (SAP) groups.
  • A control group of 30 healthy subjects was included for comparison.
  • Coronary angiography (CAG) was used to assess stenosis severity and plaque types.

Main Results:

  • Serum neopterin levels were significantly higher in AMI and UAP groups compared to SAP and control groups (P < 0.01).
  • Neopterin levels correlated with the number of affected coronary vessels (P < 0.05).
  • Type II plaques, associated with higher neopterin levels (P < 0.01), were more prevalent in AMI and UAP patients.

Conclusions:

  • Elevated serum neopterin is associated with acute and unstable forms of CHD.
  • Neopterin may contribute to athermanous plaque formation and progression.
  • Neopterin shows potential as a biomarker for identifying vulnerable plaques in coronary artery disease.

More Related Videos

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

1.2K
Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure04:20

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure

Published on: October 1, 2019

5.1K

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
769
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
699
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
502
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
632